DEF14A

Company

Dare Bioscience, Inc.

Filed

May 5, 2015

Period of Report

June 26, 2015

Accession Number

0001193125-15-172004

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →